PPARGC1A and Insulin resistance: Increased adiposity and adipocyte inflammation impair insulin signaling and contribute to the development of insulin resistance and metabolic dysfunction [50], which are characterized by the inhibition of the antioxidant genes PGC-1α and HO-1 [31].